What do people have against London EBs in this forum?
What do people have against US EBs (PJT, Evercore, PWP, Moelis, GHL, CW) in London here? As far as I'm concerned, they have great people, a nice dealflow with good EMEA M&A and RX exposure. Also pay above-average salaries and have good exits (sure, maybe less MF exits than Goldman..). And some also have a generalist model which can be good for a junior and probably a better culture than the biggest BBs. Certainly stack up pretty well against the likes of Barclays, DB, CS and Citi/BAML imo.
My fair point of view:
Pros:
- M&A and RX exposure
- Fucking great salary
Cons:
- Most EBs dont have such M&A dealflow and mostly rely on Rx
- Brand name in EU is not close to the US (Maybe apart from PJT/Evercore)
Anyways, Evercore, PJT and Lazard do have nothing in common with PWP, Moelis, GHL or CW here.
Personally I would take CS/Barclays above those ones, regarding to PJT/Evercore they are above these ones and maybe also Citi. Would place BofA a little bit above due to the high growth their experiencing and opportunities its large BS provides in the long-term.
Note: I am not keen in Rx, if you have an interest on it, fuck these BBs
Envy.
Probably because Lazard and Rothschild are the only real EBs in London
Rothschild over PJT/ Evercore? hahahahahahhahaahhahahahahahhahahahahahahahahahahahahhahahahahahahahahahhahahahahah
These little fights over whose firm is number 1 or 2 is pretty childish tbh.. Once you work, people won't care whether you are from Roth, Lazard, Evercore, PJT, etc.
When you are a junior won't matter especially because here everyone is so obsessed with the "exit" and probably the junior experience in Evercore and PJT is superior under many aspects....but later in the career you will realize that the weight of Rothschild and Lazard in Europe is difficult to beat by any other boutique
Roths UK is an absolute machine by volume and value - not even comparable to PJT UK (M&A, not Rx)
Public M&A: has most of the FTSE on retainer (part brand, part having boards stuffed full of Roths alumni). Is typically Rule 3 advisor (sell-side) on every take-private unless conflicted out (whether small or large - see Bain/Advent buying Cobham ($5bn)) and also picks up hefty buy-sides (Melrose/GKN ($10bn)). Also does a tonne of ECM advisory often with better fees than the underwriters despite having zero capital at risk - see any of the big equity raises over the last 6 months...
Private M&A: More mid-market focus but excl. Big4 (tiny deals) nobody comes close on volume. Mostly sell-side.
I don’t think anyone has anything against the EBs in London other than a few bitter and insecure people. Know people that have and would take EBs over a number of BBs. Especially PJT who’s dealflow is popping off atm both in Rx and M&A. In terms of dealflow / analyst you don’t get a much better experience.
Sorry but I don't think Greenhill is a comparable of PJT/EVR/Moelis/CW
Lol true that - neither is moelis tbh.
Anything in London is kind of an L tbh
At fugiat et magni ea pariatur consectetur. Quia cupiditate nisi est eum. Eum est neque laboriosam id eos vitae rerum magnam.
Tenetur magnam reprehenderit quas consequuntur incidunt architecto. Non dicta nihil facilis sunt error excepturi eius nam. Ea quia omnis optio voluptatibus laborum dolor.
Doloremque quia laudantium qui ad quibusdam expedita sit. Odit alias doloremque labore et. Nisi amet ut et ut voluptatem. Repellat quod et sunt distinctio rem laborum sint. Magnam eum et mollitia recusandae nulla vel sint aliquid. Ullam amet qui nulla consequatur facere.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...